Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dendritic cell (DC) endocytic machinery is a specialized system of surface receptors and intracellular pathways responsible for the capture, internalization, and processing of antigens. This machinery primarily consists of C-type lectin receptors (CLRs) such as DEC-205 (CD205), DC-SIGN (CD209), and the mannose receptor (CD206), as well as Fc receptors and scavenger receptors (2.1.2, 2.2.4). These components facilitate various forms of uptake, including receptor-mediated endocytosis, macropinocytosis, and phagocytosis, allowing DCs to sample their environment for pathogens and debris (2.2.3). Once internalized, antigens are routed to specialized endosomal and lysosomal compartments where they are processed into peptides and loaded onto MHC class I and II molecules for presentation to T cells (2.2.5). In therapeutic development, this machinery is targeted to enhance the efficacy of vaccines and immunotherapies; by conjugating antigens to ligands or antibodies specific for these receptors, researchers can ensure efficient antigen delivery to DCs to elicit potent, antigen-specific T-cell responses (2.1.1, 2.1.4). However, targeting this system requires careful co-administration of adjuvants to prevent the induction of immune tolerance rather than activation (2.1.2).
Targeted delivery of antigens to dendritic cells via receptor-mediated endocytosis to promote antigen processing and T-cell activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell endocytic machinery.